15-min delayed · Sep 11, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering GeneDx Holdings Corp, 5 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $63.00 to $90.00, a moderate spread. The average target of $78.40 sits 8% below the current $85.23. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.32 next quarter toward $1.17 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Strong Buy
Strong Buy00%
Buy5100%
Hold00%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to GeneDx Holdings Corp.
As of Sep, 5 of 5 firms rate WGS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
WGS EPS & revenue forecast
EPS · NEXT QUARTER
$0.32
Range $0.21 – $0.50 · 8 analysts · +125% YoY
Next period, 8 analysts expect GeneDx Holdings Corp. to earn $0.32 a share (range $0.21 – $0.50), versus $0.14 a year earlier. Full-year consensus is $0.13, growing to $1.17 the year after.
REVENUE · NEXT QUARTER
$142.3M
Range $139.2M – $144.2M · 8 analysts · +18% YoY
Revenue is expected to reach $142.3M (range $139.2M – $144.2M), +17.6% year-over-year. Full-year consensus is $481.6M, rising to $598.5M next year.
Top analysts covering GeneDx Holdings Corp.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on WGS.
#1
David Westenberg
Piper Sandler · Rank #244
Buy
$63.00-26.1% to target
Overall win rate
33%
+ Follow
#2
KM
Kyle Mikson
Canaccord Genuity · Rank #263
Buy
$90.00+5.6% to target
Overall win rate
34%
+ Follow
#3
Matthew Sykes
Goldman Sachs · Rank #274
Hold
$80.00-6.1% to target
Overall win rate
38%
+ Follow
#4
Mark Massaro
BTIG
Buy
$90.00+5.6% to target
Coverage
—
+ Follow
#5
Brandon Couillard
Wells Fargo
Buy
$75.00-12.0% to target
Coverage
—
+ Follow
WGS stock forecast FAQ
What is WGS's average 12-month price target?+
The 5 analysts with a live target average $78.40 for GeneDx Holdings Corp. over the next 12 months, ranging from a $90.00 high to a $63.00 low.
Is WGS stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 5 analyst ratings, 5 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for WGS?+
The Street-high target is $90.00 (Canaccord Genuity), and the Street-low is $63.00 (Piper Sandler). The average of all 5 active targets is $78.40.
How many Wall Street analysts cover WGS?+
5 analysts have an active rating on GeneDx Holdings Corp., and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering WGS?+
Among analysts who currently cover WGS, David Westenberg of Piper Sandler has the strongest overall Quantellect track record (Rank #244). Their current call is Buy with a $63.00 target.
What is GeneDx Holdings Corp.'s projected EPS for next quarter?+
The consensus estimate is $0.32 per share (range $0.21 – $0.50) across 8 analysts. Full-year EPS is projected at $0.13, rising to $1.17 the following year.
How much revenue is GeneDx Holdings Corp. expected to report next quarter?+
Consensus revenue is $142.3M (range $139.2M – $144.2M). Full-year revenue is projected at $481.6M, growing to $598.5M next year.
Have analysts been upgrading or downgrading WGS lately?+
As of Sep, 5 of 5 firms rate WGS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their WGS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
